Related Experiment Video
Updated: Jun 5, 2026
09:46
Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells
Published on: December 27, 2017
Thrombocytopenia in pregnancy.
1Cleveland Clinic Foundation, Cleveland, OH 44195, USA. mccraek@ccf.org
Hematology. American Society of Hematology. Education Program
|January 18, 2011
Summary
Thrombocytopenia, a low platelet count, is common in pregnancy. This review covers its diverse causes, diagnosis, and management, including pregnancy-specific conditions.
Area of Science:
- Obstetrics and Gynecology
- Hematology
Background:
- Thrombocytopenia (low platelet count) is a frequent complication during pregnancy.
- Causes are diverse, ranging from common conditions to those unique to pregnancy.
Purpose of the Study:
- To review the differential diagnosis of thrombocytopenia in pregnant patients.
- To discuss the pathogenesis of selected thrombocytopenic disorders.
- To outline optimal management strategies for pregnant individuals with thrombocytopenia.
Main Methods:
- Literature review of thrombocytopenia in pregnancy.
- Discussion of diagnostic approaches.
- Overview of management principles.
Main Results:
- Identified numerous etiologies of thrombocytopenia in pregnancy.
- Highlighted pregnancy-specific causes unfamiliar to some specialists.
- Described pathogenesis of key disorders.
Conclusions:
- Accurate diagnosis of thrombocytopenia in pregnancy is crucial.
- Understanding diverse etiologies, including unique pregnancy-related conditions, is essential for effective management.
- This review provides a framework for managing thrombocytopenia in pregnant patients.
Related Concept Videos
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:30Venous Thrombosis IV: Nursing Management
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:07Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
01:30Venous Thrombosis I: Introduction
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...